AGI Therapeutics flotation to raise more than expected

AGI Therapeutics, the drug firm run by former Elan executives, will float on the Alternative Investment Market on February 27, raising stg£29.2 million (€42.7 million).

18th February, 2006

AGI Therapeutics, the drug firm run by former Elan executives, will float on the Alternative Investment Market on February 27, raising stg£29.2 million (€42.7 million).

The company is confident of raising more than its initial target of €35 million after strong demand for its shares at investor roadshows. AGI, which is less than three years old, is likely to be valued at over €120 million in the flotation.

AGI’s biggest individual shareholder is co-founder and...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago